S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
Log in
NYSE:HAE

Haemonetics SEC Filings & 10K Form

$122.22
-3.02 (-2.41 %)
(As of 03/3/2021 05:06 PM ET)
Add
Compare
Today's Range
$118.93
Now: $122.22
$125.57
50-Day Range
$114.05
MA: $127.75
$139.48
52-Week Range
$63.41
Now: $122.22
$142.11
Volume839,850 shs
Average Volume390,267 shs
Market Capitalization$6.21 billion
P/E Ratio59.04
Dividend YieldN/A
Beta0.56

SEC Filings

Haemonetics (NYSE:HAE) SEC Filings

DateFilerForm TypeView
03/02/2021
8:37 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2021
8:37 PM
Haemonetics (Filer)
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2021
3:41 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
2:11 PM
Capital Research Global Investors (Filed by)
Haemonetics (Subject)
Form SC 13G/A
02/05/2021
3:51 PM
Haemonetics (Issuer)
MEELIA RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
3:46 PM
Dockendorff Charles J (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
5:21 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/02/2021
5:08 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/20/2021
5:47 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/10/2020
11:33 AM
Capital Research Global Investors (Filed by)
Haemonetics (Subject)
Form SC 13G/A
11/04/2020
5:21 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2020
5:04 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2020
4:02 PM
Goldstein Dan (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2020
3:59 PM
Burke William P. Mr. (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2020
3:55 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2020
3:21 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2020
4:04 PM
Haemonetics (Issuer)
Llorens Josep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2020
5:04 PM
ABERNATHY ROBERT E (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2020
6:38 AM
Haemonetics (Filer)
Form 8-K/A
08/04/2020
5:38 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2020
5:09 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2020
5:47 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2020
4:47 PM
Haemonetics (Issuer)
Zane Ellen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2020
4:40 PM
Haemonetics (Issuer)
Pomeroy Claire (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2020
4:36 PM
Haemonetics (Issuer)
MEELIA RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2020
4:29 PM
Haemonetics (Issuer)
KROLL MARK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2020
4:23 PM
Dockendorff Charles J (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2020
4:17 PM
COYLE MICHAEL J (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2020
4:15 PM
BURZIK CATHERINE M (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2020
4:11 PM
ABERNATHY ROBERT E (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
3:20 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
5:45 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2020
4:11 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
4:29 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
3:16 PM
Haemonetics (Filer)
Form DEFA14A
06/16/2020
5:19 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
5:16 PM
Burke William P. Mr. (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
4:55 PM
Goldstein Dan (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
4:53 PM
Haemonetics (Issuer)
Scanlan Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
4:51 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
3:39 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2020
5:04 PM
Goldstein Dan (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
4:59 PM
Haemonetics (Issuer)
Scanlan Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
4:57 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
4:54 PM
Burke William P. Mr. (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
4:52 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
5:43 AM
Haemonetics (Filer)
Form DEFA14A
06/08/2020
5:34 AM
Haemonetics (Filer)
Form DEF 14A
05/28/2020
3:23 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2020
6:06 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
5:10 PM
Goldstein Dan (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
4:51 PM
Haemonetics (Issuer)
Llorens Josep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
4:42 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
4:34 PM
Haemonetics (Issuer)
Scanlan Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
4:20 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2020
5:08 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2020
3:18 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2020
5:48 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2020
4:12 PM
Haemonetics (Issuer)
KROLL MARK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2020
7:53 AM
Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
04/08/2020
4:10 PM
Goldstein Dan (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2020
4:05 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/10/2020
5:16 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2020
4:46 PM
Haemonetics (Issuer)
Scanlan Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
5:28 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2020
3:11 PM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/04/2020
5:19 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2020
1:36 PM
Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/14/2020
5:39 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
4:24 PM
Bolorforosh Said (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
4:17 PM
Haemonetics (Issuer)
MEELIA RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2019
5:13 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2019
7:32 PM
Goldstein Dan (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2019
7:20 PM
Burke William P. Mr. (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2019
3:38 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2019
4:03 PM
Haemonetics (Issuer)
Scanlan Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2019
3:56 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2019
3:52 PM
Burke William P. Mr. (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2019
3:37 PM
Haemonetics (Issuer)
Scanlan Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2019
3:35 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2019
3:34 PM
Burke William P. Mr. (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
4:22 PM
Burke William P. Mr. (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
3:34 PM
Haemonetics (Issuer)
Scanlan Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:53 PM
Haemonetics (Issuer)
Llorens Josep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
3:46 PM
Bolorforosh Said (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2019
3:23 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2019
4:31 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2019
3:41 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
3:25 PM
GELBMAN RONALD G (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
3:20 PM
Goldstein Dan (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
4:16 AM
Haemonetics (Filer)
Form EFFECT
08/06/2019
3:05 PM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
5:04 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2019
4:17 PM
Haemonetics (Filer)
Form POS AM
07/30/2019
3:45 PM
Haemonetics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/29/2019
3:17 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2019
4:39 PM
Haemonetics (Issuer)
Zane Ellen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
4:37 PM
Haemonetics (Issuer)
Pomeroy Claire (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
4:36 PM
Haemonetics (Issuer)
MEELIA RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
4:34 PM
Haemonetics (Issuer)
KROLL MARK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.